Skip to main content
Healthcare

STAT+: Revolution Medicines’ pancreatic cancer drug has stunning commercial debut

STAT+: Revolution Medicines’ pancreatic cancer drug has stunning commercial debut

Feed excerpt — reported by STAT News

Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.